(R)-tert-Butyl (2-amino-3,3-dimethylbutyl)carbamate

Catalog No.: 
ACKWTE525
CAS No.: 
1218943-99-7
Molecular Formula: 
C11H24N2O2
Molecular Weight: 
216.32
(R)-tert-Butyl (2-amino-3,3-dimethylbutyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg96%$308.00InquiryInquiry
100mg96%$451.00InquiryInquiry
250mg96%$635.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl (2-amino-3,3-dimethylbutyl)carbamate
IUPAC Name(R)-tert-Butyl (2-amino-3,3-dimethylbutyl)carbamate
Molecular FormulaC11H24N2O2
Molecular Weight216.32
SMILESO=C(OC(C)(C)C)NC[C@H](N)C(C)(C)C
InChI KeyOTSWUUVDIYKZTD-QMMMGPOBSA-N
Synonym(R)-(2-Amino-3,3-dimethyl-butyl)-carbamic acid tert-butyl ester;(R)-tert-butyl (2-amino-3,3-dimethylbutyl)carbamate;Carbamic acid, N-[(2R)-2-amino-3,3-dimethylbutyl]-, 1,1-dimethylethyl ester;(R)-(2-Amino-3,3-dimethyl-butyl)-carbamic acid tert-butyl ester ee
CAS No.1218943-99-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKWTE525 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKWTE525 route product structure diagram
    ACKWTE5251218943-99-7
Inquiry

2. ACKWTE525 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKWTE525 route product structure diagram
    ACKWTE5251218943-99-7
Inquiry

3. ACKWTE525 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKWTE525 route product structure diagram
    ACKWTE5251218943-99-7
Inquiry

Comments (0)